Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,934 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors.
Navas TA, Mohindru M, Estes M, Ma JY, Sokol L, Pahanish P, Parmar S, Haghnazari E, Zhou L, Collins R, Kerr I, Nguyen AN, Xu Y, Platanias LC, List AA, Higgins LS, Verma A. Navas TA, et al. Among authors: verma a. Blood. 2006 Dec 15;108(13):4170-7. doi: 10.1182/blood-2006-05-023093. Epub 2006 Aug 29. Blood. 2006. PMID: 16940419 Free PMC article. Clinical Trial.
Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.
Barreyro L, Will B, Bartholdy B, Zhou L, Todorova TI, Stanley RF, Ben-Neriah S, Montagna C, Parekh S, Pellagatti A, Boultwood J, Paietta E, Ketterling RP, Cripe L, Fernandez HF, Greenberg PL, Tallman MS, Steidl C, Mitsiades CS, Verma A, Steidl U. Barreyro L, et al. Among authors: verma a. Blood. 2012 Aug 9;120(6):1290-8. doi: 10.1182/blood-2012-01-404699. Epub 2012 Jun 21. Blood. 2012. PMID: 22723552 Free PMC article.
Signal transduction inhibitors in treatment of myelodysplastic syndromes.
Bachegowda L, Gligich O, Mantzaris I, Schinke C, Wyville D, Carrillo T, Braunschweig I, Steidl U, Verma A. Bachegowda L, et al. Among authors: verma a. J Hematol Oncol. 2013 Jul 10;6:50. doi: 10.1186/1756-8722-6-50. J Hematol Oncol. 2013. PMID: 23841999 Free PMC article. Review.
Stem cell origin of myelodysplastic syndromes.
Elias HK, Schinke C, Bhattacharyya S, Will B, Verma A, Steidl U. Elias HK, et al. Among authors: verma a. Oncogene. 2014 Oct 30;33(44):5139-50. doi: 10.1038/onc.2013.520. Epub 2013 Dec 16. Oncogene. 2014. PMID: 24336326 Review.
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes.
Gañán-Gómez I, Wei Y, Starczynowski DT, Colla S, Yang H, Cabrero-Calvo M, Bohannan ZS, Verma A, Steidl U, Garcia-Manero G. Gañán-Gómez I, et al. Among authors: verma a. Leukemia. 2015 Jul;29(7):1458-69. doi: 10.1038/leu.2015.69. Epub 2015 Mar 12. Leukemia. 2015. PMID: 25761935 Free PMC article. Review.
Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia.
Will B, Vogler TO, Narayanagari S, Bartholdy B, Todorova TI, da Silva Ferreira M, Chen J, Yu Y, Mayer J, Barreyro L, Carvajal L, Neriah DB, Roth M, van Oers J, Schaetzlein S, McMahon C, Edelmann W, Verma A, Steidl U. Will B, et al. Among authors: verma a. Nat Med. 2015 Oct;21(10):1172-81. doi: 10.1038/nm.3936. Epub 2015 Sep 7. Nat Med. 2015. PMID: 26343801 Free PMC article.
5,934 results